Egypt-based healthtech startup Rology has successfully closed a growth funding round with participation from a consortium of global industry leaders, including Philips Foundation, Johnson & Johnson Impact Ventures, Sanofi Global Health Unit’s Impact Fund, and MIT Solve Innovation Future. The investment signals strong confidence in Rology’s mission to enhance radiology access in underserved communities through its AI-powered platform.
Democratising Diagnostics with AI
Founded in 2017 by Amr Abodraiaa, Moaaz Hossam, Mahmoud Eldefrawy, and Bassam Khallaf, Rology provides a zero-setup, AI-accelerated teleradiology platform. The FDA 510(k)-cleared system delivers diagnostic reporting across 12 sub-specialities and eight imaging modalities, with reports available in as little as 30 minutes. By addressing global radiologist shortages and rising imaging demand, the platform has become a critical infrastructure layer for over 300 hospitals across 13 countries, delivering over 1.3 million reports and saving an estimated 1.2 million lives.
“This round brings together mission-aligned leaders across industry, research, and impact investing to advance AI reporting and expand access to high-quality radiology across MEA,” said Amr Abodraiaa, CEO of Rology.
Strategic Backing from Global Health Leaders
The new funding comes with powerful validation from globally recognised institutions in healthcare and innovation. The investors highlighted Rology’s potential to create scalable, systemic impact.
“As a follow-on lead investor, Philips Foundation reaffirms its confidence in Rology’s innovative model that bridges the diagnostic gap and strengthens access to quality care,” said Eddine Sarroukh, Head of Philips Foundation. “This investment reflects our belief in human-centred technology that gives clinicians time back and makes advanced diagnostics available where they are needed most.”
Jon Fairest, Head of Sanofi’s Global Health Unit, commented, “AI-powered diagnostics have the potential to transform healthcare delivery in underserved regions. Rology’s platform is the kind of scalable innovation we seek to support—bridging healthcare and diagnostic gaps across LMICs and underserved settings.”
Echoing this sentiment, David Higgins, Investment Director at Johnson & Johnson Impact Ventures, noted that Rology’s cost-effective, AI-powered services provide an innovative way for patients to access care.
Fueling Expansion in Saudi Arabia and Africa
The new capital will be instrumental in accelerating Rology’s expansion across the Middle East and Africa. The company plans to strengthen its market position in Saudi Arabia, building on its 2023 acquisition of Saudi-based counterpart Arkan United. The funds will also deepen its impact in low- and middle-income countries (LMICs).
Mahmoud Eferawy, Co-Founder and Chief Medical Officer, highlighted that the round reinforces Rology’s leadership in advancing teleradiology innovation within the Kingdom.
Meanwhile, Moaaz Hossam, Co-Founder and Chief Business Officer, emphasised that the milestone will strengthen the company’s ability to expand access to rapid, high-quality radiology reporting across Kenya and other key African markets.
About Rology
Founded in 2017, Rology is an AI-assisted teleradiology platform on a mission to democratise the radiology market. By connecting hospitals and medical centres with a network of remote radiologists, the company leverages artificial intelligence to improve diagnostic accuracy, reduce turnaround times, and make high-quality medical imaging accessible to remote and underserved communities across the Middle East and Africa.
Source: Wamda
